Apolipoprotein A-1 Predicts Coronary Heart Disease Only at Low Concentrations of High-Density Lipoprotein Cholesterol: An Epidemiological Study of Japanese-Americans
Public Domain
-
2000/06/01
-
Details
-
Personal Author:
-
Description:Conventional epidemiological and clinical studies of apolipoprotein A-1 and high-density lipoprotein-cholesterol have demonstrated, when examined jointly, that high-density lipoprotein is a better predictor of coronary heart disease. This strategy does not take into account known lipid metabolic relationships. A statistical approach that takes into account apolipoprotein A-1 being a constituent of the high-density lipoprotein particle is more appropriate. Among 1,177 Japanese-American men of the Honolulu Heart Program cohort free of disease at baseline (1980-1982), 182 new coronary heart disease cases developed over a 12-year follow-up period. After removing the linear relationship with high-density lipoprotein-cholesterol, a relative measure of apoliprotein A-1 concentration was derived. Based on joint conditions of "low" and "high" relative apoliprotein A-1 concentration and < or =40 and >40 mg/dl for the high-density lipoprotein-cholesterol distribution, four groupings were created. Among relative joint groupings of high/< or =40, low/< or =40, high/>40, and low/>40, respectively, the 12-year coronary heart disease incidence varied from 28.6, 18.2, 8.3, to 11.7 cases per 1,000 person-years. A test of statistical interaction was significant (P=0.028). Additional analyses revealed coronary heart disease cases were more likely among men with triglycerides > 190 mg/dl. Observed patterns of relationships among relative apoliprotein A-1 level, high-density lipoprotein cholesterol, and triglycerides with incident coronary heart disease are consistent with patterns noted in clinical, laboratory, and transgenic animal research more capable of elucidating mechanisms of disease causation. This epidemiological study suggests similar mechanisms may be operating at a population level, and may contribute to the public health burden of coronary heart disease. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0940-5437
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:39-48
-
Volume:30
-
Issue:1
-
NIOSHTIC Number:nn:20020805
-
Citation:Int J Clin Lab Res 2000 Jun; 30(1):39-48
-
Contact Point Address:D. Sharp, NIOSH/HELD/BB, 1095 Willowdale Road (MS 4020), Morgantown, WV 26505, USA
-
Federal Fiscal Year:2000
-
Peer Reviewed:False
-
Source Full Name:International Journal of Clinical and Laboratory Research
-
Collection(s):
-
Main Document Checksum:urn:sha-512:74c5578c29354a9d5d5d6c5fd649193ae700ab3e10b025129b8df7af80597b210ff1dc090824e0f9edb7fabca4af0e595a9fc82e5e3bc4e674d82b8188e5b352
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like